BNTC Earnings Date: Nov 13, 2026 (Estimated) — Benitec Biopharma Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is BNTC's next earnings date?
Benitec Biopharma Inc. (BNTC) is expected to report Q1 2027 earnings on Friday, November 13, 2026 at 5:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.27.
How did BNTC do in its last earnings report?
In its most recent report on Sep 14, 2026 (Q4 2026), Benitec Biopharma Inc. posted EPS of -$0.26 versus the -$0.26 estimate, a beat of 0.0%. Revenue was $0 against a $13.7M estimate. The stock's 1-day post-earnings move was -8.5%.
How much does BNTC stock move after earnings?
BNTC beat EPS estimates in 4 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 4.4% (up or down) in the day after earnings.
About Benitec Biopharma Inc.
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 | Q4 2026 | -0.26 | -0.26 | +0.00% | $0 | ✅ Beat | -8.53% | -9.93% | -28.56% |
| 2026-05-14 | Q3 2026 | -0.27 | -0.24 | +11.11% | $0 | ✅ Beat | +1.72% | -5.67% | -4.03% |
| 2026-02-12 | Q2 2026 | -0.23 | -0.26 | -13.04% | $0 | ❌ Miss | -2.66% | -6.95% | +0.86% |
| 2025-11-14 | Q1 2026 | -0.33 | -0.22 | +33.33% | $0 | ✅ Beat | +2.81% | +0.76% | -5.70% |
| 2025-09-22 | Q4 2025 | -0.30 | -0.42 | -40.00% | $0 | ❌ Miss | +0.45% | +1.86% | +20.67% |
| 2025-02-14 | Q2 2025 | -0.58 | -0.33 | +43.10% | $0 | ✅ Beat | +15.98% | +16.49% | +58.14% |
| 2024-11-14 | Q1 2025 | -0.43 | -0.48 | -11.63% | $0 | ❌ Miss | +2.69% | -1.92% | +20.96% |
| 2024-09-26 | Q4 2024 | -0.43 | -0.60 | -39.53% | $0 | ❌ Miss | -0.11% | +15.91% | +24.20% |
Showing last 8 quarters.